Investment in health care, R&D robust in China and Hong Kong despite COVID-19
As health care firms in China and Hong Kong race to respond to the challenges of the global COVID-19 pandemic, they are experiencing sustained investment (mostly from China funds and wealthy Chinese investors), and are benefiting from recent regulatory changes and technological... Read More